These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 32011436)

  • 1. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.
    Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X
    Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis.
    Zhu Y; Yang T; Wu Q; Yang X; Hao J; Deng X; Yang S; Gu C; Wang Z
    Cancer Med; 2020 Aug; 9(16):5699-5707. PubMed ID: 32628360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of S100P for pancreatic cancer: a meta-analysis.
    Hu H; Zhang Q; Huang C; Shen Y; Chen X; Shi X; Tang W
    Tumour Biol; 2014 Oct; 35(10):9479-85. PubMed ID: 25123266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
    Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of circulating tumor cells for lung cancer: A systematic review and meta-analysis.
    Ye Y; Li SL; Wang JJ; Liu B
    Medicine (Baltimore); 2019 Mar; 98(12):e14936. PubMed ID: 30896658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
    Wang K; Wang X; Pan Q; Zhao B
    Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of blood-based liquid biopsies in hepatocellular carcinoma: A protocol for systematic review and meta-analysis.
    Zhang T; Yin M; Wang L; Cao W; Zhong S
    Medicine (Baltimore); 2020 Oct; 99(41):e22594. PubMed ID: 33031312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsies in thyroid cancers: a systematic review and meta-analysis.
    Zeyghami W; Hansen MU; Jakobsen KK; Groenhøj C; Feldt-Rasmussen U; von Buchwald C; Hahn CH
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37882489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 11. The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer.
    Lyu M; Zhou J; Ning K; Ying B
    Onco Targets Ther; 2019; 12():2539-2552. PubMed ID: 31040697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of circulating exosomal glypican-1 in pancreatic cancer: a meta-analysis.
    Qiao Z; Wang E; Bao B; Tan X; Chen H; Wang D; Yuan L
    Lab Med; 2024 Sep; 55(5):543-552. PubMed ID: 38470244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of circulating lncRNAs as biomarkers of digestive system cancers: A systematic review and meta-analysis.
    Fang X; Wang D; Pu K; Zhang Z; Wang H; Wang H; Zheng Y; Wang Y; Guan Q; Zhou Y
    Expert Rev Mol Diagn; 2020 Oct; 20(10):1051-1062. PubMed ID: 33138648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
    Yang Y; Yan S; Tian H; Bao Y
    Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis.
    Meng QC; Qiu WW; Wen ZQ; Wang HC; Shan ZZ; Yuan Z; Huang XY
    Tumori; 2015; 101(2):199-205. PubMed ID: 25838251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
    Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
    Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of diagnostic value of serum Carbohydrate antigen 199 in pancreatic cancer.
    Zhang Y; Jiang L; Song L
    Minerva Med; 2016 Feb; 107(1):62-9. PubMed ID: 26824636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.